Completed
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Type of Sarcoma:
Uterine Leiomyosarcoma
Drug:
Gemcitabine and Docetaxel
Accrual Status:
Completed
Overall Study Principal Investigator:
Martee L. Hensley, MD
Memorial Sloan Kettering Cancer Institute